Cammareri, Patrizia <br/><br/>
Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma.  [electronic resource] 

 -  Nature communications  08 2016 
 - 12493 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2041-1723 
<br/><br/><label>Standard No.: </label>10.1038/ncomms12493  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--adverse effects<br/>Biopsy<br/>Carcinogenesis--genetics<br/>Carcinoma, Squamous Cell--chemically induced<br/>Cell Line, Tumor<br/>DNA Mutational Analysis--methods<br/>Female<br/>Humans<br/>Indoles--adverse effects<br/>Male<br/>Melanoma--drug therapy<br/>Mice<br/>Mice, Inbred Strains<br/>Mutation<br/>Neoplasms, Experimental--chemically induced<br/>Protein Serine-Threonine Kinases--genetics<br/>Proto-Oncogene Proteins B-raf--antagonists & inhibitors<br/>Proto-Oncogene Proteins p21(ras)--genetics<br/>Receptor, Transforming Growth Factor-beta Type I<br/>Receptor, Transforming Growth Factor-beta Type II<br/>Receptors, Transforming Growth Factor beta--genetics<br/>Signal Transduction--drug effects<br/>Skin Neoplasms--chemically induced<br/>Stem Cells<br/>Sulfonamides--adverse effects<br/>Transforming Growth Factor beta--metabolism<br/>Tumor Suppressor Protein p53--genetics<br/>Vemurafenib<br/>Exome Sequencing